|
|
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF
|
NeoPharm, Inc. Announces First Quarter 2008 Financial Results
|
Trubion Pharmaceuticals, Q1 2008 Earnings Call Transcript
|
PDL BioPharma Reports First Quarter 2008 Financial Results
|
Medpace Director of Clinical Pharmacology, Jim Wei, Md, PhD, Embarks on a Regulatory Policy Speaking Tour in C
|
Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in C
|
FDA and the Paul Ehrlich Institute (Germany) Approve Pluristem's Regulatory Submissions in Support of a Phase
|
Advaxis Taps Former ''Big Pharma'' FDA Special
|
Biopharma CMO Market Report
|
Alexion Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript
|
Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and
|
Advaxis Taps Former ''Big Pharma'' FDA Specialist
|
Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial
|
Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
|
King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III
|
King & Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Ev
|
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leu
|
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leu
|
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leu
|
ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia
|
